Peanut oral immunotherapy decreases IgE to Ara h 2 and Ara h 6 but does not enhance sensitization to cross-reactive allergens - 19/04/17
Doi : 10.1016/j.jaci.2016.09.054
Riikka Uotila, MD a 
, Anna Kaarina Kukkonen, MD, PhD a, Dario Greco, PhD b, Anna Susanna Pelkonen, MD, PhD a, Mika Juhani Mäkelä, MD, PhD a
, Anna Kaarina Kukkonen, MD, PhD a, Dario Greco, PhD b, Anna Susanna Pelkonen, MD, PhD a, Mika Juhani Mäkelä, MD, PhD a a Skin and Allergy Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
b Institute of Biotechnology, University of Helsinki, Helsinki, Finland
| Supported by the Foundation for Pediatric Research (140061), the Helsinki University Research Funds (TYH2012227, TYH2013228, TYH2014233), the Foundation for Allergy Research (granted 2015), the Päivikki and Sakari Sohlberg Foundation (granted 2014), the Finnish Society of Allergology and Immunology (granted 2015), the Allergy and Asthma Federation (granted 2014), the Yrjö Jahnsson Foundation (6793), and the Academy of Finland (grants 275151 and 292307). Thermo Fisher Scientific provided laboratory kits for the IgG4 analyses. The sponsors had no involvement in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the article for publication. Trial registration: Clinicaltrials.gov: NCT01502878. |
|
| Disclosure of potential conflict of interest: D. Greco is supported by the Academy of Finland (grants 275151 and 292307). R. Uotila is supported by the Foundation for Pediatric Research, the Helsinki University Research Funds, the Foundation for Allergy Research, the Päivikki and Sakari Sohlberg Foundation, the Finnish Society of Allergology and Immunology, the Allergy and Asthma Federation, and the Yrjö Jahnsson Foundation. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2016
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 139 - N° 4
P. 1393 - avril 2017 Regresar al número
Artículo precedente
- Combined immunodeficiency and hypoglycemia associated with mutations in hypoxia upregulated 1
- Emma M. Haapaniemi, Christopher L. Fogarty, Salla Keskitalo, Shintaro Katayama, Helena Vihinen, Mette Ilander, Satu Mustjoki, Kaarel Krjutškov, Markku Lehto, Timo Hautala, Ove Eriksson, Eija Jokitalo, Vidya Velagapudi, Markku Varjosalo, Mikko Seppänen, Juha Kere
- Tofacitinib relieves symptoms of stimulator of interferon genes (STING)–associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173
- Jieun Seo, Jung-Ah Kang, Dong In Suh, Eun-Byeol Park, Cho-Rong Lee, Sun Ah Choi, Soo Yeon Kim, Yeji Kim, Sang-Heon Park, Michael Ye, Soon-Hak Kwon, June Dong Park, Byung Chan Lim, Dong Hun Lee, Suk-Jo Kang, Murim Choi, Sung-Gyoo Park, Jong-Hee Chae
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?